The ROE as of November 2024 (TTM) for GlycoMimetics, Inc. (GLYC) is -116.81%

According to GlycoMimetics, Inc.’s latest financial reports and current stock price. The company's current ROE is -116.81%. This represents a change of 257.06% compared to the average of -32.72% of the last 4 quarters.

GlycoMimetics, Inc. (GLYC) Historical ROE (quarterly & annually)

How has GLYC ROE performed in the past?

The mean historical ROE of GlycoMimetics, Inc. over the last ten years is -66.00%. The current -116.81% ROE has changed 77.00% with respect to the historical average. Over the past ten years (40 quarters), GLYC's ROE was at its highest in in the June 2015 quarter at 18.81%. The ROE was at its lowest in in the December 2022 quarter at -68.04%.

GlycoMimetics, Inc. (GLYC) ROE by Quarter and Year

Discovering the peaks and valleys of GlycoMimetics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

GlycoMimetics, Inc. (GLYC) Average ROE

How has GLYC ROE performed in the past?

The current ROE of GlycoMimetics, Inc. (GLYC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

GlycoMimetics, Inc. (GLYC) ROE vs. Peers

How is GLYC’s ROE compared to its peers?

GlycoMimetics, Inc.’s ROE is less than Mineralys Therapeutics, Inc. (0%), greater than Foghorn Therapeutics Inc. (-42.61%), less than Inventiva S.A. (140.34%), less than Dyne Therapeutics, Inc. (550.46%), greater than aTyr Pharma, Inc. (-68.85%), greater than Trevi Therapeutics, Inc. (-56.83%), greater than Cue Biopharma, Inc. (-49.92%), greater than AN2 Therapeutics, Inc. (-142.93%), greater than BioAtla, Inc. (-54.72%), greater than Assembly Biosciences, Inc. (-169.69%), greater than Spero Therapeutics, Inc. (-121.55%), less than Achilles Therapeutics plc (20.70%), greater than Instil Bio, Inc. (-47.36%), greater than Neoleukin Therapeutics, Inc. (-55.57%), greater than null (-47.64%),

Build a custom stock screener for GlycoMimetics, Inc. (GLYC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GlycoMimetics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

GlycoMimetics, Inc. (GLYC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like GlycoMimetics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.